The role of the anaphylatoxins in health and disease
- PMID: 19477527
- PMCID: PMC2725201
- DOI: 10.1016/j.molimm.2009.04.027
The role of the anaphylatoxins in health and disease
Abstract
The anaphylatoxin (AT) C3a, C5a and C5a-desArg are generally considered pro-inflammatory polypeptides generated after proteolytic cleavage of C3 and C5 in response to complement activation. Their well-appreciated effector functions include chemotaxis and activation of granulocytes, mast cells and macrophages. Recent evidence suggests that ATs are also generated locally within tissues by pathogen-, cell-, or contact system-derived proteases. This local generation of ATs is important for their pleiotropic biologic effects beyond inflammation. The ATs exert most of the biologic activities through ligation of three cognate receptors, i.e. the C3a receptor, the C5a receptor and the C5a receptor-like, C5L2. Here, we will discuss recent findings suggesting that ATs regulate cell apoptosis, lipid metabolism as well as innate and adaptive immune responses through their impact on antigen-presenting cells and T cells. As we will outline, such regulatory functions of ATs and their receptors play important roles in the pathogenesis of allergy, autoimmunity, neurodegenerative diseases, cancer and infections with intracellular pathogens.
Similar articles
-
Anaphylatoxins: their role in bacterial infection and inflammation.Immunol Res. 2007;37(3):161-75. doi: 10.1007/BF02697367. Immunol Res. 2007. PMID: 17873401 Review.
-
The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.Inflamm Allergy Drug Targets. 2009 Jul;8(3):236-46. doi: 10.2174/187152809788681038. Inflamm Allergy Drug Targets. 2009. PMID: 19601884 Review.
-
The new face of anaphylatoxins in immune regulation.Immunobiology. 2012 Feb;217(2):225-34. doi: 10.1016/j.imbio.2011.07.016. Epub 2011 Jul 23. Immunobiology. 2012. PMID: 21856033 Review.
-
Complement in allergy and asthma.Curr Opin Immunol. 2002 Dec;14(6):705-8. doi: 10.1016/s0952-7915(02)00410-7. Curr Opin Immunol. 2002. PMID: 12413519 Review.
-
Anaphylatoxins and infectious and non-infectious inflammatory diseases.Mol Immunol. 2001 Aug;38(2-3):175-87. doi: 10.1016/s0161-5890(01)00041-4. Mol Immunol. 2001. PMID: 11532279 Review.
Cited by
-
Deficiency of C5L2 increases macrophage infiltration and alters adipose tissue function in mice.PLoS One. 2013 Apr 22;8(4):e60795. doi: 10.1371/journal.pone.0060795. Print 2013. PLoS One. 2013. PMID: 23630572 Free PMC article.
-
C3a and C5a facilitates the metastasis of myeloma cells by activating Nrf2.Cancer Gene Ther. 2021 Apr;28(3-4):265-278. doi: 10.1038/s41417-020-00217-0. Epub 2020 Sep 2. Cancer Gene Ther. 2021. PMID: 32873871
-
C5aR1 Activation Drives Early IFN-γ Production to Control Experimental Toxoplasma gondii Infection.Front Immunol. 2020 Jul 8;11:1397. doi: 10.3389/fimmu.2020.01397. eCollection 2020. Front Immunol. 2020. PMID: 32733463 Free PMC article.
-
Complement System Part II: Role in Immunity.Front Immunol. 2015 May 26;6:257. doi: 10.3389/fimmu.2015.00257. eCollection 2015. Front Immunol. 2015. PMID: 26074922 Free PMC article. Review.
-
Complement System Part I - Molecular Mechanisms of Activation and Regulation.Front Immunol. 2015 Jun 2;6:262. doi: 10.3389/fimmu.2015.00262. eCollection 2015. Front Immunol. 2015. PMID: 26082779 Free PMC article. Review.
References
-
- Abe M, Shibata K, Akatsu H, Shimizu N, Sakata N, Katsuragi T, Okada H. Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats. J Immunol. 2001;167:4651–4660. - PubMed
-
- Addis-Lieser E, Köhl J, Chiaramonte MG. Opposing regulatory roles of complement factor 5 in the development of bleomycin-induced pulmonary fibrosis. J Immunol. 2005;175:1894–1902. - PubMed
-
- Afagh A, Cummings BJ, Cribbs DH, Cotman CW, Tenner AJ. Localization and cell association of C1q in Alzheimer's disease brain. Exp Neurol. 1996;138:22–32. - PubMed
-
- Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, Ziolko SK, James JA, Snitz BE, Houck PR, Bi W, Cohen AD, Lopresti BJ, DeKosky ST, Halligan EM, Klunk WE. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol. 2008;65:1509–1517. - PMC - PubMed
-
- Akiyama H, Arai T, Kondo H, Tanno E, Haga C, Ikeda K. Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis Assoc Disord. 2000;14 1:S47–S53. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous